Clinical Trial Update: Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SCT800 for prophylaxis in previously treated patients with severe Hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SCT800

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED